Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Cancer Cell|January 1, 2013
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancerJie Liang, Masayuki Nagahashi, Eugene Y Kim, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 3, 2019
Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapyMariko Asaoka, Kazutaka Narui, Nobuyasu Suganuma, et al.
Breast Cancer (Tokyo, Japan)|March 21, 2024
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancerKazutaka Narui, Toshihiko Satake, Takashi Ishikawa, et al.
Anticancer Research|March 31, 2021
First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort StudyShinya Yamamoto, Kazutaka Narui, Takashi Ishikawa, et al.
Hepatology (Baltimore, Md.)|November 4, 2014
Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expressionMasayuki Nagahashi, Kazuaki Takabe, Runping Liu, et al.
World Journal of Oncology|November 29, 2023
Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control StudyChiho Suzuki, Akimitsu Yamada, Kei Kawashima, et al.
Cancer Research|January 21, 2018
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer MetastasisMasayuki Nagahashi, Akimitsu Yamada, Eriko Katsuta, et al.
Molecular Cancer Research : MCR|March 11, 2018
ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast CancerAkimitsu Yamada, Masayuki Nagahashi, Tomoyoshi Aoyagi, et al.
Breast Cancer Research : BCR|May 29, 2026
Real-world data for a CDK4/6 inhibitor, palbociclib, as 1st- or 2nd-line therapy in HR+/HER2- metastatic breast cancer: a multicenter prospective cohort studyTakashi Ishikawa, Yukari Uemura, Hirohito Seki, et al.
Breast Cancer (Tokyo, Japan)|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational studyShigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, et al.
Pageof 11